- Home
- BBDC vs NKTR Comparison
BBDC vs NKTR Comparison
Compare BBDC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBDC
- NKTR
- Stock Information
- Founded
- BBDC 2006
- NKTR 1990
- Country
- BBDC United States
- NKTR United States
- Employees
- BBDC N/A
- NKTR N/A
- Industry
- BBDC Diversified Financial Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- BBDC Finance
- NKTR Health Care
- Exchange
- BBDC Nasdaq
- NKTR Nasdaq
- Market Cap
- BBDC 971.7M
- NKTR 1.2B
- IPO Year
- BBDC 2007
- NKTR 1994
- Fundamental
- Price
- BBDC $9.04
- NKTR $59.63
- Analyst Decision
- BBDC Buy
- NKTR Strong Buy
- Analyst Count
- BBDC 3
- NKTR 6
- Target Price
- BBDC $9.67
- NKTR $91.67
- AVG Volume (30 Days)
- BBDC 522.6K
- NKTR 866.2K
- Earning Date
- BBDC 11-06-2025
- NKTR 11-06-2025
- Dividend Yield
- BBDC 11.50%
- NKTR N/A
- EPS Growth
- BBDC N/A
- NKTR N/A
- EPS
- BBDC 0.95
- NKTR N/A
- Revenue
- BBDC $280,314,000.00
- NKTR $74,934,000.00
- Revenue This Year
- BBDC N/A
- NKTR N/A
- Revenue Next Year
- BBDC N/A
- NKTR N/A
- P/E Ratio
- BBDC $9.54
- NKTR N/A
- Revenue Growth
- BBDC N/A
- NKTR N/A
- 52 Week Low
- BBDC $7.66
- NKTR $6.48
- 52 Week High
- BBDC $10.85
- NKTR $65.79
- Technical
- Relative Strength Index (RSI)
- BBDC 57.38
- NKTR 55.17
- Support Level
- BBDC $8.52
- NKTR $59.23
- Resistance Level
- BBDC $8.79
- NKTR $65.79
- Average True Range (ATR)
- BBDC 0.17
- NKTR 4.35
- MACD
- BBDC 0.08
- NKTR -0.50
- Stochastic Oscillator
- BBDC 79.27
- NKTR 52.17
About BBDC Barings BDC Inc.
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.